Adverse events associated with medium‐and long‐term use of opioids for chronic non‐cancer pain: an overview of Cochrane Reviews

C Els, TD Jackson, D Kunyk, VG Lappi… - Cochrane Database …, 2017 - cochranelibrary.com
Background Chronic pain is common and can be challenging to manage. Despite increased
utilisation of opioids, the safety and efficacy of long‐term use of these compounds for chronic …

Pharmacological treatments of neuropathic pain: The latest recommendations

N Attal - Revue neurologique, 2019 - Elsevier
We provide an up-to-date review of the pharmacological treatment of neuropathic pain with
emphasis on the latest evidence-based recommendations for its pharmacological treatment …

Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines

L Manchikanti, AM Kaye, NN Knezevic… - Pain …, 2017 - scholarlycommons.pacific.edu
Background: Opioid use, abuse, and adverse consequences, including death, have
escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse …

[HTML][HTML] Prescription of controlled substances: benefits and risks

CV Preuss, A Kalava, KC King - 2019 - europepmc.org
purpose. Manufacturing. Distribution. Exportation and sale. The Controlled Substance Act
established five drug schedules and classified them to control their manufacture and …

[HTML][HTML] NP safe prescribing of controlled substances while avoiding drug diversion

AM Dydyk, DC Sizemore, LM Haddad, L Lindsay… - 2020 - europepmc.org
Objectives: Review general guideleines for safe prescribing practices. Describe behaviors
that suggest drug diversion or drug-seeking and appropriate responses. Outline expected …

Safety of opioids in osteoarthritis: outcomes of a systematic review and meta-analysis

N Fuggle, E Curtis, S Shaw, L Spooner, O Bruyère… - Drugs & aging, 2019 - Springer
Objective We aimed to assess the safety of opioids in the management of osteoarthritis (OA)
in a systematic review and meta-analysis of randomized, placebo-controlled trials. Methods …

High‐dose opioids for chronic non‐cancer pain: an overview of Cochrane Reviews

C Els, TD Jackson, R Hagtvedt, D Kunyk… - Cochrane Database …, 2023 - cochranelibrary.com
Objectives To describe the evidence from Cochrane Reviews and overviews regarding the
efficacy and safety of high‐dose opioids (defined as 200 mg morphine equivalent or more …

[HTML][HTML] Tennessee controlled substance prescribing for acute and chronic pain

A Dydyk, D Sizemore, L Trachsel, S Dulebohn, B Porter - StatPearls, 2023 - statpearls.com
Opioid use and abuse for acute and chronic pain are a significant problem in the United
States and Tennesee.[1][2][3] The rate of overdose-related to the use of illicit opioids has …

2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV

RD Bruce, J Merlin, PJ Lum, E Ahmed… - Clinical Infectious …, 2017 - academic.oup.com
Pain has always been an important part of human immunodeficiency virus (HIV) disease
and its experience for patients. In this guideline, we review the types of chronic pain …

Tapentadol versus tramadol: a narrative and comparative review of their pharmacological, efficacy and safety profiles in adult patients

L Roulet, V Rollason, J Desmeules, V Piguet - Drugs, 2021 - Springer
We conducted a narrative review of the literature to compare the pharmacological, efficacy
and safety profiles of tapentadol and tramadol, and to assess the clinical interest of …